Granite Investment Partners’s Integra LifeSciences IART Stock Holding History

Granite Investment Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-36,624	Closed	-$1.72M	–	275
2020 Q2	$1.72M	Buy	36,624 +1,029	+3%	+$50.6K	0.08%	192
2020 Q1	$1.59M	Sell	35,595 -751	-2%	-$39.4K	0.1%	181
2019 Q4	$2.12M	Buy	36,346 +13,307	+58%	+$792K	0.1%	189
2019 Q3	$1.38M	Buy	23,039 +866	+4%	+$51.6K	0.07%	204
2019 Q2	$1.24M	Buy	+22,173	New	+$1.14M	0.07%	203

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Granite Investment Partners's IART Position: Q3 2020 in Review

Granite Investment Partners sold out of Integra LifeSciences (IART) in Q3 2020, closing a stake of 36,624 shares — an estimated $1.72M sold.

Granite Investment Partners first reported a position in IART in Q2 2019 and held it in 5 quarters. The position peaked at $2.12M in Q4 2019. 237 funds tracked by Wall St. Rank hold IART as of Q3 2020.

Granite Investment Partners reported no remaining Integra LifeSciences position as of Q3 2020 after selling out during the quarter.
Granite Investment Partners sold 36,624 Integra LifeSciences shares in Q3 2020, an estimated $1.72M.
Granite Investment Partners first reported a position in Integra LifeSciences in Q2 2019 and held it in 5 quarters.
Granite Investment Partners's Integra LifeSciences position peaked at $2.12M in Q4 2019.
237 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2020.

Based on Granite Investment Partners's 13F filing for Q3 2020, filed 6 Nov 2020.